Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Welcome to the TNL Beta! We are actively improving this experience.

Share Feedback

Source study found

Story checked

Lower immunity after lockdown likely impacted outbreak of deadly strep A infections (opens in a new tab)

medicalxpress.com · 2026-11-05

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

2 claims go further than the study. 3 other points were not covered by the paper.

  • 2 supported
  • 2 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Notice: Analysis is currently derived from study abstracts. Full-text paper analysis capabilities are currently in development.

Share this check

Help improve NewsLink

Tell us what worked or what needs attention in this check.

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

Two of seven claims overstate the study. Two of seven check out. Three claims the study doesn't address.

  • 2 supported
  • 2 overstated
  • 3 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

7 claims in this story

Showing all 7 claimsChoose a verdict to focus the list.

Claim 1 of 7OverstatedResearchers studying the winter 2022/2023 outbreak of group A streptococcus infections in Scotland found strong evidence that the outbreak was not caused by a new virulent strain of the bacteria, but was likely the result of pandemic isolation precautions.View evidenceHide evidence

Why this verdict

The paper profile supports the genomic part: abstract-level evidence argues against emergence of a novel hypervirulent emm1 clone. It also says the epidemiology is consistent with increased host susceptibility after reduced exposure. However, the headline-level framing that the outbreak was likely the result of pandemic isolation precautions states a causal explanation more strongly than the retrospective/ecologic abstract evidence can establish. The headline therefore outruns the causal strength of the evidence.

1

Study evidence

Marked increase in national iGAS incidence occurred in late 2022 and early 2023.

“National surveillance data from 2014-2024 were analyzed to characterize iGAS incidence.”
2

Study evidence

Post-pandemic emm1 isolates were not genetically distinct from pre-pandemic emm1 isolates across genome-wide polymorphisms, accessory gene content (including virulence and antimicrobial-resistance determinants), mobile genetic elements, or chromosomal structural variants.

“Hybrid whole genome sequencing was used to comprehensively genetically characterize 404 emm1 isolates collected from invasive and tonsillitis infections.”
Claim 2 of 7OverstatedThe study suggests that the surge in strep A cases was due to lowered immunity levels as a result of less mixing and exposure to bacteria during lockdown precautions, not because a strain of the bacteria had become more dangerous.View evidenceHide evidence

Why this verdict

The study does suggest non-genetic explanations and reports no evidence that post-pandemic emm1 isolates became genetically distinct or hypervirulent. But the claim that the surge was due to lowered immunity levels implies a causal mechanism and measured immunity more strongly than the abstract supports; the profile only says the patterns are consistent with increased host susceptibility after reduced exposure.

1

Study evidence

Marked increase in national iGAS incidence occurred in late 2022 and early 2023.

“National surveillance data from 2014-2024 were analyzed to characterize iGAS incidence.”
2

Study evidence

Post-pandemic emm1 isolates were not genetically distinct from pre-pandemic emm1 isolates across genome-wide polymorphisms, accessory gene content (including virulence and antimicrobial-resistance determinants), mobile genetic elements, or chromosomal structural variants.

“Hybrid whole genome sequencing was used to comprehensively genetically characterize 404 emm1 isolates collected from invasive and tonsillitis infections.”
Claim 3 of 7Not coveredScotland saw serious strep A infections rise to four times their normal level in children after having fallen by about 70% during COVID-19 restrictions.View evidenceHide evidence

As statedfour times their normal level in children; about 70% during COVID-19 restrictions

Why this verdict

The abstract-level profile supports a marked late-2022/early-2023 iGAS increase in Scotland that disproportionately affected children, and it notes pandemic-era changes. But it does not provide the numerical claims that infections rose to four times normal in children or fell by about 70% during restrictions.

1

Study evidence

Marked increase in national iGAS incidence occurred in late 2022 and early 2023.

“National surveillance data from 2014-2024 were analyzed to characterize iGAS incidence.”
Claim 4 of 7Not coveredThe outbreak caused 28 child deaths across the U.K.'s four nations over a five-month period, and older adults were also significantly affected.View evidenceHide evidence

As stated28 child deaths over a five-month period

Why this verdict

The abstract-level profile supports that older adults were disproportionately affected. It does not report 28 child deaths, a five-month period, or data across all four U.K. nations; the profiled paper evidence is centered on Scotland iGAS surveillance.

1

Study evidence

Marked increase in national iGAS incidence occurred in late 2022 and early 2023.

“National surveillance data from 2014-2024 were analyzed to characterize iGAS incidence.”
Claim 5 of 7Not coveredTo test possible explanations, the researchers examined every serious strep A infection recorded in Scotland from 2014 to 2024, totaling 3,408 cases, and sequenced more than 400 samples of the common emm1 strain collected before, during and after the pandemic.View evidenceHide evidence

As stated3,408 cases; more than 400 samples

Why this verdict

The abstract-level profile supports national Scotland iGAS surveillance from 2014–2024 and hybrid WGS of 404 emm1 isolates, which is consistent with 'more than 400 samples.' However, it does not verify that every serious strep A infection was examined or the stated total of 3,408 cases.

1

Study evidence

Marked increase in national iGAS incidence occurred in late 2022 and early 2023.

“National surveillance data from 2014-2024 were analyzed to characterize iGAS incidence.”
2

Study evidence

Post-pandemic emm1 isolates were not genetically distinct from pre-pandemic emm1 isolates across genome-wide polymorphisms, accessory gene content (including virulence and antimicrobial-resistance determinants), mobile genetic elements, or chromosomal structural variants.

“Hybrid whole genome sequencing was used to comprehensively genetically characterize 404 emm1 isolates collected from invasive and tonsillitis infections.”
Claim 6 of 7SupportedGenetic analysis found no sign of a new or more dangerous strain; post-pandemic bacteria were essentially the same as pre-pandemic bacteria, with no new toxin genes or new antibiotic resistance.View evidenceHide evidence

Why this verdict

The profile supports that post-pandemic emm1 isolates were not genetically distinct from pre-pandemic isolates across genome-wide polymorphisms, accessory genes including virulence and antimicrobial-resistance determinants, mobile elements, and structural variants. This supports the claim that the genomic analysis found no evidence of a novel or more dangerous emm1 strain, with the caveat that the profiled genomic conclusion is specific to sampled emm1 isolates.

1

Study evidence

Post-pandemic emm1 isolates were not genetically distinct from pre-pandemic emm1 isolates across genome-wide polymorphisms, accessory gene content (including virulence and antimicrobial-resistance determinants), mobile genetic elements, or chromosomal structural variants.

“Hybrid whole genome sequencing was used to comprehensively genetically characterize 404 emm1 isolates collected from invasive and tonsillitis infections.”
Claim 7 of 7SupportedThe researchers also proposed that flu and other viruses, including RSV, may have contributed to the surge alongside lowered immunity after lockdowns.View evidenceHide evidence

Why this verdict

The profile supports that the iGAS surge temporally coincided with increased influenza and RSV activity and that the epidemiology is consistent with increased host susceptibility after reduced exposure, with a possible contributing role for respiratory viruses. The claim is appropriately hedged as 'may have contributed.'

1

Study evidence

Marked increase in national iGAS incidence occurred in late 2022 and early 2023.

“National surveillance data from 2014-2024 were analyzed to characterize iGAS incidence.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The iGAS surge was not associated with a proportional increase in bacteremia.

    This abstract-level result is material to whether the surge reflected a change in clinical presentation or severity, but it is not reflected in the presented story claims or caveats.

    From Retrospective national surveillance analysis

  • The genomic conclusion is limited to sampled emm1 lineage isolates from Scotland, including invasive and tonsillitis sources; it does not rule out every possible change in all GAS lineages.

    The story notes emm1 sequencing in one claim but elsewhere phrases the finding more broadly as 'the bacteria' or 'a strain of the bacteria' becoming more dangerous, without clearly emphasizing that the genomic test was specific to emm1 isolates.

    From comparative genomic analysis (hybrid WGS)

  • The abstract profile provides qualitative summaries of incidence trends and affected age groups but not detailed incidence rates, statistical measures, or the story's specific numerical case totals and percentage changes.

    The presented story gives specific figures such as fourfold increase, 70% decline, and 3,408 cases, but those quantitative details are not verifiable from the supplied abstract-depth paper profile.

    From Retrospective national surveillance analysis

3 things the story did carry across
  • National surveillance data from Scotland, 2014–2024, showed a marked iGAS increase in late 2022/early 2023 that disproportionately affected children and older adults.
  • The timing of the iGAS surge coincided with increased influenza and RSV activity, but the comparison is ecologic and does not establish individual-level causation or coinfection.
  • Hybrid whole-genome sequencing of 404 emm1 isolates found post-pandemic emm1 isolates were not genetically distinct from pre-pandemic isolates, including virulence and antimicrobial-resistance determinants.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataDescribe national trends in invasive group A streptococcus (iGAS) incidence in Scotland (2014–2024), including the post‑pandemic surge and affected age groups, and assess whether the surge coincides with changes in clinical presentation (e.g., bacteremia) and with respiratory virus activity (influenza/RSV).Retrospective national surveillance analysisExpand

In plain English

National surveillance data (Scotland, 2014–2024) show a marked increase in invasive group A streptococcus (iGAS) incidence in late 2022–early 2023 that disproportionately affected children and older adults; the surge was not accompanied by a proportional rise in bacteremia and was temporally coincident with increased influenza and respiratory syncytial virus (RSV) activity.

Key findings

  • Marked increase in national iGAS incidence occurred in late 2022 and early 2023.
  • The post‑pandemic surge disproportionately affected children and older adults.
“National surveillance data from 2014-2024 were analyzed to characterize iGAS incidence.”
What this piece can’t prove
  • Retrospective surveillance design limits causal inference; temporal/ecologic comparisons cannot establish individual‑level coinfection or causation.
  • Abstract provides qualitative summaries without detailed incidence rates, statistical measures, or methods for trend testing.

2 further details could not be confirmed from the summary.

2ex vivo humanDetermine whether the post‑pandemic iGAS surge is explained by emergence of a novel/hypervirulent emm1 clone by comparing genomics of emm1 isolates collected pre‑ vs post‑pandemic (including invasive and tonsillitis sources).comparative genomic analysis (hybrid WGS)Expand

In plain English

Comparative population-genomic analysis of 404 emm1 Streptococcus pyogenes isolates (invasive and tonsillitis sources) collected in Scotland (2014–2024) using hybrid whole-genome sequencing. Post-pandemic emm1 isolates showed no genetic distinctness from pre-pandemic isolates across genome-wide polymorphisms, accessory gene content (including virulence and antimicrobial-resistance determinants), mobile genetic elements, or chromosomal structural variants, arguing against emergence of a novel hypervirulent emm1 clone as the driver of the post-pandemic iGAS surge.

Key findings

  • Post-pandemic emm1 isolates were not genetically distinct from pre-pandemic emm1 isolates across genome-wide polymorphisms, accessory gene content (including virulence and antimicrobial-resistance determinants), mobile genetic elements, or chromosomal structural variants.
“Hybrid whole genome sequencing was used to comprehensively genetically characterize 404 emm1 isolates collected from invasive and tonsillitis infections.”
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

Candidate

Clinical manifestations and outcomes of invasive group B streptococcal infection in nonpregnant adults.

2016 · Crossref

Source (opens in a new tab)

And 9 more candidates considered.